Medicines board withdraws Ranitidine products from pharmacies

User Rating: 0 / 5

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

By Grace Donga 

The Pharmacy, Medicines and Poison Board has withdrawn Ranitidine products from drug outlets across the country. 

This is according to a statement signed by the board’s Chief Executive Officer, Moses Chisale.

Chisale explains that they have received some safety concerns about the products. Ranitidine also known by its brand name as Zantac, Q`1is commonly used to relieve and prevent heartburn.

Prescription strengths are also used to treat and prevent more serious ulcers in the stomach and intestines.

According to the statement, the products have been withdrawn from the market pending results on further investigations.

All health care providers, health facilities pharmaceutical outlets and the public are advised to quarantine any remaining stock of ranitidine until further notice.

The statement further urges the pharmaceutical outlets to provide details of such stock to the board within the next 72 hours with information on dosage, form, strength manufacturer, distributor, quantities batch numbers and expiry dates.

Chisale advices all prescribers to offer alternative advice and patients taking Ranitidine should consult their physician.


MAIN NUMBER +265 1875400
NEWSROOM +265 1873067

LILONGWE +265 212251272